Rafferty Asset Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.77M Buy
97,629
+40,562
+71% +$1.98M 0.02% 411
2025
Q1
$2.91M Sell
57,067
-20,965
-27% -$1.07M 0.01% 486
2024
Q4
$3.52M Sell
78,032
-23,231
-23% -$1.05M 0.01% 485
2024
Q3
$3.76M Buy
101,263
+803
+0.8% +$29.8K 0.01% 479
2024
Q2
$3.07M Sell
100,460
-193,844
-66% -$5.93M 0.01% 520
2024
Q1
$8.56M Sell
294,304
-45,659
-13% -$1.33M 0.03% 326
2023
Q4
$9.37M Buy
339,963
+133,676
+65% +$3.68M 0.04% 296
2023
Q3
$4.62M Buy
206,287
+13,172
+7% +$295K 0.03% 400
2023
Q2
$7.85M Buy
193,115
+35,672
+23% +$1.45M 0.04% 290
2023
Q1
$7.63M Sell
157,443
-54,007
-26% -$2.62M 0.05% 257
2022
Q4
$8.07M Buy
211,450
+82,292
+64% +$3.14M 0.07% 257
2022
Q3
$6.48M Buy
129,158
+7,606
+6% +$382K 0.07% 254
2022
Q2
$4.87M Sell
121,552
-37,838
-24% -$1.52M 0.04% 279
2022
Q1
$5.95M Buy
159,390
+17,237
+12% +$643K 0.04% 334
2021
Q4
$5.66M Buy
142,153
+62,662
+79% +$2.5M 0.03% 336
2021
Q3
$2.96M Buy
79,491
+18,754
+31% +$698K 0.02% 485
2021
Q2
$2.57M Buy
60,737
+3,733
+7% +$158K 0.02% 589
2021
Q1
$2.7M Buy
57,004
+42,657
+297% +$2.02M 0.02% 547
2020
Q4
$876K Sell
14,347
-29,166
-67% -$1.78M 0.01% 539
2020
Q3
$2.03M Buy
43,513
+24,122
+124% +$1.13M 0.02% 412
2020
Q2
$984K Buy
19,391
+12,361
+176% +$627K 0.01% 550
2020
Q1
$314K Sell
7,030
-52,623
-88% -$2.35M 0.01% 425
2019
Q4
$2.87M Sell
59,653
-29,771
-33% -$1.43M 0.04% 232
2019
Q3
$3.02M Sell
89,424
-10,888
-11% -$368K 0.05% 231
2019
Q2
$4.51M Sell
100,312
-9,754
-9% -$439K 0.08% 182
2019
Q1
$4.14M Buy
+110,066
New +$4.14M 0.07% 167